Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Acceptance, Facilitators and Barriers of the Electronic Patient Record (ePA) in Germany: A Qualitative Interview Study Among Active Users, Nonactive Users, and Non-Users
ABSTRACT
Background:
In January 2025, Germany changed its electronic patient record (elektronische Patientenakte [ePA]) from an opt-in to an opt-out model, making an ePA available to most individuals with statutory health insurance unless they actively objected. Formal availability, however, does not necessarily result in active use. Little is known about whether facilitators and barriers differ between individuals who actively use the ePA, those who have an ePA but do not use it (nonactive users), and those who deliberately opt out (non-users).
Objective:
This study explored and compared facilitators and barriers to ePA use across these three user groups and examined how the identified factors relate to an established technology acceptance framework.
Methods:
We conducted a qualitative interview study within the “ePA4all” project. Active users, nonactive users, and non-users were recruited for semistructured interviews via purposive and snowball sampling using multiple channels. Data were analyzed using structured qualitative content analysis according to Kuckartz, combining deductive and inductive approaches: facilitators and barriers served as deductive main categories, while subcategories were developed inductively. Resulting categories were interpreted using the Unified Theory of Acceptance and Use of Technology (UTAUT), extended by the dimensions of trust and data privacy.
Results:
Between May and December 2025, we conducted 61 interviews with 21 active users, 20 nonactive users, and 20 non-users in Germany. Active users perceived substantial potential value but continued to experience access barriers and limited integration of the ePA into routine care. Nonactive users recognized potential benefits but reported limited personal relevance, insufficient knowledge, and anticipated access complexity. Non-users raised concerns about data privacy, security, governance, and institutional trust. Across user groups, simplified access to the ePA application, targeted information, and clearer integration into routine care emerged as key prerequisites for wider adoption.
Conclusions:
The transition to an opt-out model addresses the availability of the ePA but does not by itself ensure activation, meaningful use, or acceptance of its governance model. Different forms of non-use reflected different underlying barriers: limited activation and information among individuals with an unused ePA, and trust-, governance-, and autonomy-related concerns among many opt-out participants. Implementation strategies should therefore distinguish between enabling access and use and supporting informed decisions about participation. Clinical Trial: German Clinical Trials Register DRKS00037053; https://www.drks.de/search/de/trial/DRKS00037053; registration date: June 5, 2025 (retrospectively registered)
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.